Gordon Fox • October 14, 2021
Weight loss improves HCM patients’ heart health

Weight management is a challenge for many. Losing weight is a challenge for nearly everyone who tries it. It can be more difficult for many HCM patients because we often take drugs that slow us down. It’s also hard to study: researchers can assign different groups to different diets, but how can they tell who follows the diet closely, loosely, or not at all? How can they know how much exercise people really get?  This problem is more challenging because we also know that weight loss is important for many people, especially those with HCM.

A recent pilot study (20 subjects all with BMI greater than 30, which is labeled “obese”) by a group in Italy, the UK, and the US, though, provides some initial evidence of beneficial effects on the heart from a weight loss and exercise program. Participants used the Mediterranean diet plus an exercise program. Before the study, and at 12 and 24 months, they were examined using echocardiograms , electrocardiography , Holter monitor , CPET , cardiac MRI , and some blood tests. Participants also were given questionnaires asking how well they followed the diet and exercise protocols.

Not surprisingly, some participants lost a lot of weight while others lost less. Regardless of how much they lost, though, there was a significant pattern: the more weight lost, the better the results were for a reduction in several measurements related to the risk of developing atrial fibrillation, increasing their ability to exercise, and in the pressure in the pulmonary artery.

This small pilot study will hopefully lead to more extensive research. But in any case, it should help give us some of the motivation we need to lose some of that extra weight!

Source: Heart Failure Clinics , 17: 303-313. doi://10.1016/j.hfc.2021.01.003

Many readers may not be able to access this article without paying a fee. Some of the authors also published a popular article about this research.

HCMA Blog

A Caucasian man and women in lab coats stand over laboratory equipment.
April 30, 2025
Medical Management means using medicines and other non-invasive therapies to relieve symptoms of hypertrophic cardiomyopathy and other thick heart diseases. Knowing what is out there and what is being studied will help you navigate your treatment with your healthcare providers.
On a green background, a line drawing of a head that has complicated arrows pointing outwards
By Gordon Fox April 25, 2025
Part 2 of a series on making decisions in HCM. A key reason is that decision making is so difficult is that most decisions involve more than one risk.
Hypertrophic Obsctructive Cardiomyopathy
By Erica Friedman April 22, 2025
Bristol Myers Squibb announces that Camzyos has been approved for Obstructive Hypertrophic Cardiomyopathy in Japan.
More Posts